Linolenic acid 463-40-1 High Cost-Effective
Product Name: | Linolenic acid |
Synonyms: | LINOLENSAEURE NATUERLICH*;LINOLENIC ACID, STANDARD FOR GC;alpha-Linolenicacid70%;Linolenic acid, tech., remainder linoleic acid, 90%;A-linolenic;9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)-;LINOLENICACID(FREE);LINOLENICACID,PRACTICAL |
CAS: | 463-40-1 |
MF: | C18H30O2 |
MW: | 278.43 |
EINECS: | 207-334-8 |
Product Categories: | Fatty & Aliphatic Acids, Esters, Alcohols & Derivatives;Biochemistry;-;Fatty Acid Derivatives & Lipids;Higher Fatty Acids & Higher Alcohols;Unsaturated Higher Fatty Acids;Glycerols;Biological and chemical |
Mol File: | 463-40-1.mol |
|
Linolenic acid Chemical Properties |
Melting point | -11 °C(lit.) |
Boiling point | 230-232 °C1 mm Hg(lit.) |
density | 0.914 g/mL at 25 °C(lit.) |
refractive index |
n |
FEMA | 3380 | 9,12-OCTADECADIENOIC ACID (48%) AND 9,12,15-OCTADECATRIENOIC ACID (52%) |
Fp | >230 °F |
storage temp. | 2-8°C |
form | Liquid |
color | Clear colorless to light yellow |
Specific Gravity | 0.91 |
Water Solubility | INSOLUBLE |
Merck | 14,5506 |
BRN | 1727693 |
InChIKey | DTOSIQBPPRVQHS-PDBXOOCHSA-N |
CAS DataBase Reference | 463-40-1(CAS DataBase Reference) |
NIST Chemistry Reference | 9,12,15-Octadecatrienoic acid, (Z,Z,Z)-(463-40-1) |
EPA Substance Registry System | 9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)-(463-40-1) |
Safety Information |
Risk Statements | 36/37/38 |
Safety Statements | 26-36-37/39 |
RIDADR | UN1170 - class 3 - PG 2 - Ethanol |
WGK Germany | 1 |
F | 8-10-23 |
HS Code | 29161500 |
MSDS Information |
Provider | Language |
---|---|
Linolenic acid | English |
SigmaAldrich | English |
ACROS | English |
Linolenic acid Usage And Synthesis |
Overview | The alpha-linolenic acid (ALA 18:3w) an omega-3 (n-3) fatty acid, is an essential fatty acid (EFA) that cannot be synthesized by the body and therefore must be supplied by dietary sources. ALA is abundant in certain plant foods including walnuts, rapeseed (canola), several legumes, flaxseed, and green leafy vegetables.[1] ALA is the precursor of three important longer-chain n-3 fatty acids, eicosapentaenoic acid (EPA 20:5w3), docosapentaenoic acid (DPAw3 22:5w3), and docosahexaenoic acid (DHA 22:6w3), which have vital roles in brain development and function, cardiovascular health, and inflammatory response.[2-5] Omega-3 fatty acids are incorporated into the membrane lipid bilayer in virtually all body cells and affect membrane composition, eicosanoid biosynthesis, cell signaling cascades, and gene expression[6]. |
Absorption and metabolism of ALA |
As a rule, dietary fats are absorbed very efficiently from the digestive tract, and ALA is no exception. Burdge 16 recently reported that absorption levels of ALA are 96% or more. There are several possible metabolic fates for ALA that enters the bloodstream. The body can store the fatty acids in adipose tissue, use them for acetyl-CoA or energy production through b-oxidation, synthesize other non-essential saturated or monounsaturated fatty acids (MUFA), or convert them to longer-chain n-3 polyunsaturated fatty acids (PUFA) in the liver. The activity of the desaturation/elongation pathway is of unique importance as it is responsible for the synthesis of EPA and DHA. What is presently understood concerning conversion of ALA to EPA, DPAw3, and DHA is that the first step in the pathway, addition of a fourth double bond by D 6 desaturase, is considered to be the rate-limiting step. This is followed by elongation (addition of two carbon atoms) and an additional desaturation by the enzyme D 5 desaturase, with the product being 20:5n-3 or EPA. Several possibilities have been suggested for the precise pathway for production of DHA (22:6n-3) from EPA in humans. It was assumed that the conversion of DPAw3 to DHA would be carried out by a D4 desaturase but, thus far, little or no D4 desaturase has been found. Sprecher[8] has provided evidence for elongation of 22:5w3 to 24:5w3,which is then desaturated by the rate limiting D 6 desaturase to yield a 24:6w3. Two carbons are then cleaved in the peroxisomes to yield DHA that is then exported to the reticuloendothelial system. Thus, the insertion of the last double bond in DHA production in human metabolism may be rather indirect and somewhat inefficient. There are some doubts as to the validity of the Sprecher shunt, but it provides a possible explanation for the small proportions of DHA produced and the build up of DPAw3, despite ample ALA available in foods and in body tissues. Alpha-linolenic acid is partially converted to EPA in humans (8–20%), while conversion rates of ALA to DHA are estimated at 0.5–9%[9, 10]. The sex difference in metabolism is well known. Studies in women of reproductive age showed a substantially greater (2.5-fold) rate of conversion of ALA to EPA than that measured in healthy men. Thus, the ability to produce long-chain metabolites is gender dependent. It appears that women have a lower partitioning of ALA to b-oxidation, leaving more of it available for conversion to EPA[7, 11]. Other possible explanations include a direct effect of estrogen on conversion rates[7, 12]. Gender differences have also been observed in the conversion rates of ALA to DHA. In males it is estimated that only 0.5–4% of ALA is converted to DHA while in females the rates are thought to be as high as 9%[11, 12]. It is hypothesized that demands for DHA by the fetus during pregnancy may stimulate female physiology to more readily synthesize this fatty acid. |
CAS NO:28314-80-9
CAS NO:161957-55-7
CAS NO:2252-50-8
CAS NO:350-29-8
CAS NO:2215-77-2
CAS NO:603-80-5
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View